Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN (2022) World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol

Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24(Supplement5):v1–95

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR (2019) Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol 15(7):405–417

Article  PubMed  PubMed Central  Google Scholar 

Jamjoom AM, Gahtani AY, Jamjoom AB, Jamjoom A, Algahtani A, Jamjoom A (2021) Predictors of citation rates in high-impact glioblastoma clinical trials. Cureus 13(11)

Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107:207–212

Article  PubMed  Google Scholar 

Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

Article  CAS  PubMed  Google Scholar 

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21(Supplement5):v1–100

Article  PubMed  PubMed Central  Google Scholar 

Pritchard A (1969) Statistical bibliography or bibliometrics. J Doc 25:348

Google Scholar 

Hicks D, Wouters P, Waltman L, De Rijcke S, Rafols I (2015) Bibliometrics: the Leiden Manifesto for research metrics. Nature 520(7548):429–431

Article  PubMed  Google Scholar 

Łaba AE, Ziółkowski P (2021) Trends in glioblastoma treatment research: an analysis of clinical trials and literature. Neurol Neurochir Pol 55(3):269–280

Article  PubMed  Google Scholar 

Nieder C, Astner ST, Grosu AL (2012) Glioblastoma research 2006–2010: pattern of citation and systematic review of highly cited articles. Clin Neurol Neurosurg 114(9):1207–1210

Article  PubMed  Google Scholar 

Akmal M, Hasnain N, Rehan A, Iqbal U, Hashmi S, Fatima K et al (2020) Glioblastome multiforme: a bibliometric analysis. World Neurosurg 136:270–282

Article  PubMed  Google Scholar 

Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X et al (2022) Research on application of tumor treating fields in glioblastoma: a bibliometric and visual analysis. Front Oncol 12:1055366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blei DM, Ng AY, Jordan MI (2003) Latent dirichllocation. J Mach Learn Res

Griffiths TL, Steyvers M (2004) Finding scientific topics. Proc Natl Acad Sci U S A

Pons P, Latapy M (2006) Computing communities in large networks using random walks. J Graph Algorithms Appl 10(2):191–218

Article  Google Scholar 

Kamada T, Kawai S (1989) An algorithm for drawing general undirected graphs. Inf Process Lett 31(1):7–15

Article  Google Scholar 

Aria M, Cuccurullo C (2017) Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informet 11(4):959–975

Article  Google Scholar 

Erosheva E, Fienberg S, Lafferty J (2004) Mixed-membership models of scientific publications. Proc Natl Acad Sci 101(suppl1):5220–5227

Article  CAS  PubMed  PubMed Central  Google Scholar 

De la Hoz-M J, Fernández-Gómez MJ, Mendes S, LDAShiny (2021) An R package for exploratory review of scientific literature based on a Bayesian probabilistic model and machine learning tools. Mathematics 9(14):1671

Article  Google Scholar 

Blei DM, Jordan MI (2006) Variational inference for Dirichlet process mixtures. Bayesian Anal 1(1 A):121–144

Google Scholar 

Chang J, Boyd-Graber J, Gerrish S, Wang C, Blei DM (2009) Reading tea leaves: How humans interpret topic models. In: Advances in Neural Information Processing Systems 22 - Proceedings of the 2009 Conference

Lau JH, Grieser K, Newman D, Baldwin T (2011) Automatic labelling of topic models. In: ACL-HLT 2011 - Proceedings of the 49th Annual Meeting of the Association for Computational Linguistics: Human Language Technologies

Xiong H, Cheng Y, Zhao W, Liu J (2019) Analyzing scientific research topics in manufacturing field using a topic model. Comput Ind Eng

Gabriel KR (1971) The biplot graphic display of matrices with application to principal component analysis. Biometrika

Villardón MPG (1986) Una alternativa de representación simultánea: HJ-Biplot. Qüestiió: quaderns d’estadística i investigació operativa 13–23

Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol 15(suppl2):ii1–56

PubMed  PubMed Central  Google Scholar 

Guan X, Wang Y, Sun Y, Zhang C, Ma S, Zhang D et al (2021) CTLA4-mediated immunosuppression in glioblastoma is associated with the infiltration of macrophages in the tumor microenvironment. J Inflamm Res 14:7315

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grossman SA, Fisher JD, Piantadosi S, Brem H (1998) The new approaches to brain tumor therapy (NABTT) CNS consortium: organization, objectives, and activities. Cancer Control 5(2):107–114

Article  CAS  PubMed  Google Scholar 

Wykes V, Zisakis A, Irimia M, Ughratdar I, Sawlani V, Watts C (2020) Importance and evidence of extent of resection in glioblastoma. J Neurol Surg Cent Eur Neurosurg 82(01):75–86

Google Scholar 

Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2(11):1460–1469

Article  PubMed  PubMed Central  Google Scholar 

Iorgulescu B (2017) OS04. 3 extent of resection and overall survival in risk adjusted and exact matched analyses of 22,928 glioblastoma (all molecular subtypes) patients. Neuro Oncol 19(suppl3):iii7–iii7

Article  PubMed Central  Google Scholar 

Begagić E, Pugonja R, Bečulić H, Čeliković A, Tandir Lihić L, Kadić Vukas S et al (2023) Molecular targeted therapies in Glioblastoma Multiforme: a systematic overview of global trends and findings. Brain Sci 13(11):1602

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Pan L, Sheng X, fang, Chen S, Dai Jzhong (2016) Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: first results in Chinese patients. Asia Pac J Clin Oncol 12(1):e23–e29

Article  PubMed  Google Scholar 

Badruddoja MA, Pazzi M, Sanan A, Schroeder K, Kuzma K, Norton T et al (2017) Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer Chemother Pharmacol 80(4):715–721

Article  CAS  PubMed  Google Scholar 

Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M et al (2019) Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Oncol 20(1):110–119

Article  CAS  PubMed  Google Scholar 

Yeo ECF, Brown MP, Gargett T, Ebert LM (2021) The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy. Cells 10(3):607

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong Z, Wang Y, Ma W (2018) Vaccination in the immunotherapy of glioblastoma. Hum Vaccin Immunother 14(2):255–268

Article  PubMed  Google Scholar 

Suryawanshi YR, Schulze AJ (2021) Oncolytic viruses for malignant glioma: on the verge of success? Viruses 13(7):1294

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filippone A, Lanza M, Mannino D, Raciti G, Colarossi C, Sciacca D et al (2022) PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression. Cancer Immunol Immunother 71(9):2067–2075

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ratnam NM, Gilbert MR, Giles AJ (2019) Immunotherapy in CNS cancers: the role of immune cell trafficking. Neuro Oncol 21(1):37–46

Article  CAS  PubMed  Google Scholar 

Kang X, Wang Y, Liu P, Huang B, Zhou B, Lu S et al (2023) Progresses, challenges, and prospects of CRISPR/Cas9 gene-editing in Glioma studies. Cancers (Basel) 15(2):396

Article  CAS  PubMed  Google Scholar 

Choi BD, Yu X, Castano AP, Darr H, Henderson DB, Bouffard AA et al (2019) CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer 7(1):304

Article  PubMed  PubMed Central  Google Scholar 

Rousseau R (2014) Forgotten founder of bibliometrics. Nature 510(7504):218

Article  PubMed  Google Scholar 

Stoyanov GS, Lyutfi E, Georgieva R, Georgiev R, Dzhenkov DL, Petkova L et al (2022) Reclassification of glioblastoma multiforme according to the 2021 World Health Organization classification of central nervous system tumors: a single institution report and practical significance. Cureus.